respiratori
infect
caus
signific
morbid
mortal
worldwid
although
immun
respons
requir
elimin
respiratori
pathogen
uncheck
damag
surround
tissu
block
primari
lung
function
base
knowledg
immun
tcell
activ
sever
pathway
immun
intervent
could
appli
howev
rel
intervent
target
immun
cell
respond
antigen
member
tumour
necrosi
factor
receptor
famili
express
surfac
cell
sever
inflammatori
condit
recent
inhibit
prove
benefici
influenza
viru
infect
review
highlight
recent
advanc
manipul
molecul
appli
inflammatori
condit
caus
virus
lung
respiratori
infect
account
four
million
death
worldwid
year
lower
respiratori
tract
infect
third
lead
caus
death
worldwid
prioriti
vaccin
develop
public
recognit
threat
respiratori
infect
recent
increas
follow
emerg
sever
acut
respiratori
syndromeassoci
coronaviru
elimin
respiratori
virus
reli
recruit
activ
lymphocyt
lung
activ
often
excess
caus
bystand
tissu
damag
airway
occlus
therefor
fine
balanc
exist
abil
immun
system
clear
viru
damag
respons
caus
delic
architectur
lung
immunerel
problem
particularli
evid
children
less
one
year
age
airway
small
fulli
develop
well
elderli
unfortun
exampl
exuber
immun
respons
caus
sever
complic
provid
vaccin
trial
perform
formalininactiv
prepar
respiratori
syncyti
viru
rsv
enhanc
diseas
sever
result
hospitalis
caus
vaccinerel
death
mice
vaccin
follow
intranas
rsv
challeng
caus
weight
loss
cachexia
occlus
airway
inflammatori
lymphocyt
eosinophil
deplet
immunecel
subset
inflammatori
cytokin
indic
diseas
associ
excess
immun
respons
detriment
outcom
occur
result
one
follow
physic
occlus
airway
ii
product
inflammatori
mediat
enter
system
circul
tumour
necrosi
factor
tnf
exampl
caus
cachexia
fever
appetit
suppress
concentr
lung
exceed
certain
level
system
spread
occur
iii
damag
caus
biolog
action
immun
cell
lymphocyt
potent
sourc
cytokin
helper
cytotox
cell
produc
ifng
tnf
viral
infect
turn
recruit
immun
cell
lung
case
tnf
caus
death
cell
express
appropri
receptor
cytotox
cell
natur
killer
nk
cell
lyse
viral
infect
target
program
cell
death
apoptosi
rate
viral
infect
inflammatori
cell
death
might
exceed
abil
lung
microenviron
remov
apoptot
cell
contribut
occlus
inflamm
develop
antivir
vaccin
hamper
detriment
effect
earli
clinic
trial
age
intend
recipi
strategi
use
viru
evad
elimin
immun
system
treatment
effect
establish
viral
infect
specif
particular
viral
strain
would
therefor
great
valu
debilit
effect
infect
caus
occlus
airway
immun
cell
strategi
inhibit
inflammatori
respons
sought
two
main
tcell
subset
c
helper
th
lymphocyt
c
cytotox
lymphocyt
ctl
c
cell
divid
base
upon
cytokin
secret
cell
review
c
cell
help
cell
cognat
interact
andor
secret
solubl
mediat
cytokin
c
cell
also
potent
produc
cytokin
kill
pathogeninfect
cell
tumour
cell
directli
product
cytokin
cell
contribut
significantli
clinic
symptom
associ
mani
lung
viral
infect
regul
inhibit
cell
might
therefor
therapeut
potenti
respiratori
infect
tcell
respons
separ
sever
discret
phase
activ
expans
effector
memori
point
cell
perform
effector
action
might
occur
expans
effector
phase
tcell
respons
wherea
induct
memori
occur
contract
late
effector
phase
tcell
receptor
tcr
recogn
small
peptid
fragment
antigen
present
major
histocompat
molecul
mhc
mhc
class
ctl
mhc
class
ii
th
cell
mhc
molecul
constitut
express
low
level
profession
antigenpres
cell
apc
b
cell
dendrit
cell
macrophag
also
upregul
induc
varieti
cell
type
inflamm
progress
cell
full
effector
function
especi
entri
memori
pool
requir
varieti
addit
signal
precis
requir
sequenc
cooper
among
signal
maintain
tcell
respons
prevent
cell
death
begin
determin
cytokin
assist
initi
tcell
prolifer
varieti
addit
costimulatori
signal
cell
apc
requir
expans
surviv
entri
memori
pool
figur
three
broad
group
molecul
pivot
tcell
respons
cytokin
receptor
famili
control
variou
aspect
tcell
function
immunoglobulin
ig
superfamili
member
ico
tnf
receptor
superfamili
exampl
constitut
express
rest
cell
bind
apc
transmit
signal
synergis
tcr
signal
promot
sustain
tcell
respons
ii
decreas
number
tcr
engag
requir
effect
tcell
activ
iii
induc
express
sever
cytokin
although
costimul
essenti
activ
cell
enter
cell
cycl
requir
memori
tcell
respons
depend
model
system
express
rest
cell
bind
express
apc
activ
cell
might
also
function
earli
tcell
activ
recent
evid
mice
suggest
affect
cell
cycl
sustain
tcell
surviv
sever
divis
rather
influenc
number
divid
cell
inhibitori
molecul
upregul
limit
clonal
expans
review
major
cell
stage
die
apoptosi
receiv
surviv
signal
progress
memori
pool
rapidli
reactiv
counter
futur
antigen
insult
tcellexpress
known
provid
necessari
signal
continu
tcell
surviv
unlik
present
cell
express
within
h
tcell
activ
express
requir
tcrmhcpeptid
interact
although
signal
enhanc
express
express
absenc
reexpress
data
yet
avail
much
faster
within
h
rest
previous
activ
cell
express
c
c
cell
depend
experiment
system
use
note
howev
cell
type
macrophag
dendrit
cell
nk
cell
eosinophil
might
also
express
tabl
review
ligand
l
late
costimulatori
molecul
also
induc
profession
apc
lipopolysaccharid
ig
crosslink
b
cell
cellsurfac
express
report
cell
importantli
also
present
inflam
endotheli
cell
might
therefor
mediat
migrat
cell
inflammatori
site
anoth
induc
costimul
ico
induc
costimulatori
molecul
also
induc
within
h
tcell
prime
bind
h
apc
howev
express
ico
appear
slightli
earlier
requir
less
stringent
signal
bind
tnfreceptorassoci
factor
traf
initi
sever
signal
pathway
also
bind
unlik
tnf
receptor
famili
member
bind
activ
akt
upregul
antiapoptot
gene
bclxl
costimulatori
tnfreceptor
molecul
induc
cell
surviv
nfkb
jun
ntermin
kinas
review
precis
signal
pathway
involv
still
elucid
present
costimulatori
tnfreceptor
molecul
seem
share
common
signal
event
although
analysi
might
show
specif
precis
combin
signal
time
occur
rel
tcell
activ
happen
context
lung
microenviron
cell
initi
enter
inflam
site
directli
circul
secondari
lymphoid
organ
blood
activ
antigen
peptid
present
mhc
molecul
lymph
node
associ
inflammatori
site
cell
acquir
chemokin
receptor
home
molecul
enabl
entri
nonlymphoid
inflam
tissu
respiratori
tract
contain
lymphoid
tissu
nose
nasalassoci
lymphoid
tissu
nalt
small
foci
follicl
predominantli
b
cell
associ
bronchi
although
reduc
age
scatter
lymphocyt
throughout
lung
parenchyma
although
virtual
absent
healthi
individu
lower
airway
associ
constitut
secondari
lymph
node
possess
classic
affer
effer
lymphat
mediastin
lymph
node
induc
follow
infect
display
typic
characterist
secondari
lymphoid
tissu
retract
inflamm
subsid
lung
encount
vast
array
potenti
antigen
materi
signific
role
lung
apc
therefor
induct
toler
mediat
lung
dendrit
cell
produc
induc
develop
regulatori
cell
depend
costimul
icosicosl
interact
propens
product
howev
might
inadvert
induc
allerg
cell
despit
express
molecul
alveolar
macrophag
poor
costimul
cell
also
produc
signific
quantiti
vigor
tcell
respons
occur
threat
exce
immunesuppress
environ
nasal
airway
epitheli
cell
express
molecul
impli
particip
tcell
prime
howev
major
tcell
activ
thought
occur
lungassoci
lymph
node
beyer
et
al
show
viral
infect
number
activ
pulmonari
apc
increas
despit
heterogen
variou
surfac
molecul
lung
dendrit
cell
virtual
noth
known
express
recent
discov
costimulatori
molecul
propos
event
regard
costimulatorymolecul
kinet
lung
viral
infect
shown
figur
despit
near
absenc
knowledg
tempor
spatial
express
costimulatori
molecul
ligand
sever
research
investig
effect
manipul
restrict
express
late
costimulatori
molecul
antigenactiv
cell
make
ideal
therapeut
target
immun
intervent
manipul
affect
cell
recent
activ
antigen
leav
repertoir
intact
review
discuss
manipul
costimulatori
molecul
infect
respiratori
tract
diseas
lung
condit
see
strategi
use
combat
respiratori
infect
mostli
dictat
pathogen
pathogen
caus
direct
patholog
might
suit
strategi
enhanc
immun
reduct
immun
howev
could
benefit
individu
infect
pathogen
induc
excess
inflammatori
infiltr
promot
tcellmedi
immun
achiev
use
agonist
antibodi
costimulatori
molecul
solubl
vectorexpress
form
ligand
exampl
adenoviralexpress
bind
activ
cell
bind
cell
enhanc
influenzaspecif
human
c
cell
although
agonist
antibodi
promot
influenza
specif
c
cell
effect
ill
lung
inflamm
known
similarli
fusion
protein
bind
activ
cell
promot
immun
lung
cryptococcu
neoforman
infect
enhanc
pathogen
clearanc
reduc
pulmonari
eosinophilia
effect
depend
induct
andor
ifng
therefor
administr
costimulatori
molecul
agonist
provid
novel
adjuv
role
specif
cell
respond
vaccin
infect
might
appropri
promot
costimulatori
molecul
upregul
antigenactiv
cell
especi
target
constitut
express
molecul
possibl
ico
could
promot
surviv
larger
proport
cell
might
caus
immunopatholog
autoimmun
data
regard
inhibit
costimulatori
molecul
infect
lung
frequent
result
presenc
sever
reagent
knockout
mice
order
import
follow
tcell
activ
murin
model
fusion
protein
bind
molecul
apc
compet
bind
prevent
pneumon
caus
saccharopolyspora
rectivirgula
reduc
influenzavirusspecif
ifng
product
antibodi
titr
number
virusspecif
c
cell
although
influenza
viru
still
elimin
kinet
clearanc
delay
complic
use
solubl
two
form
receptor
seem
subtli
differ
role
howev
might
provid
subtl
intervent
opportun
mutat
inhibit
influenzainduc
inflamm
without
prevent
viral
clearanc
possibl
interf
nonpathogenspecif
cell
anoth
potenti
drawback
intranas
influenza
viru
infect
mice
result
reduc
antivir
c
c
cell
acut
phase
memori
pool
effect
primari
memori
respons
lend
support
hypothesi
act
concurr
least
close
signal
recent
data
hendrik
et
al
show
cooper
c
tcell
respons
influenza
viru
infect
compens
lack
influenzaspecif
tcell
respons
lung
tcell
prime
mediastin
lymph
node
wherea
mice
lack
molecul
tcell
respons
virtual
absent
influenc
virusspecif
tcell
respons
appear
restrict
site
viral
replic
splenic
c
cell
unaffect
addit
mice
lack
show
reduc
recal
c
tcell
respons
influenza
viru
challeng
mode
action
molecul
might
differ
subtli
depend
site
studi
affect
cell
cycl
wherea
particularli
lung
assist
surviv
antigenactiv
c
cell
major
studi
role
ico
inhibit
lung
conduct
model
asthma
allergi
howev
one
studi
bertram
et
al
report
antiinfluenza
respons
intraperiton
infect
icosknockout
mice
absenc
ico
reduc
antibodi
respons
primari
figur
coordin
activ
lymphocyt
acut
pulmonari
viral
infect
infect
respiratori
epithelium
alveolar
macrophag
dendrit
cell
eg
influenza
viru
respiratori
syncyti
viru
caus
releas
inflammatori
cytokin
chemokin
recruit
immun
cell
lung
epitheli
cell
kill
replic
viru
ingest
antigen
present
cell
apc
togeth
directli
infect
apc
migrat
expand
lungassoci
lymph
node
mediastin
lymph
node
cell
enter
lymph
node
blood
activ
viral
antigen
present
apc
activ
cell
depend
costimulatori
interact
result
express
altern
chemokin
receptor
adhes
molecul
facilit
entri
activ
cell
inflam
lung
b
day
lung
infect
cell
expand
upregul
late
costimulatori
molecul
possibl
cell
migrat
site
viral
replic
via
blood
note
inflam
endotheli
cell
also
express
might
facilit
movement
cell
lung
lung
activ
occur
interact
activ
apc
epitheli
cell
upregul
costimulatori
molecul
c
day
level
tcell
recruit
activ
maxim
probabl
express
cell
accumul
around
airway
blood
vessel
disrupt
function
togeth
excess
inflammatori
cytokin
product
caus
clinic
symptom
infect
sweat
weight
loss
cachexia
appetit
suppress
viru
elimin
patient
surviv
day
inflammatori
infiltr
subsid
activationinduc
cell
death
mediastin
lymph
node
reduc
size
antigenspecif
cell
surviv
contract
process
migrat
spleen
memori
cell
clariti
omit
induc
costimulatori
molecul
ico
induc
much
faster
precis
time
costimulatori
molecul
express
affect
precis
pathogen
dose
infect
rechalleng
day
primari
infect
influenzaspecif
c
cell
level
half
observ
wildtyp
mice
might
associ
lack
product
c
cell
knockout
mice
rout
infect
data
avail
viral
clearanc
immun
patholog
appear
crucial
late
secondari
c
tcell
respons
influenza
viru
infect
mice
display
normal
c
tcell
respons
primari
infect
impair
secondari
infect
addit
solubl
inhibit
tcell
respons
influenza
peptid
mice
effect
tcell
popul
dramat
absent
agonist
antibodi
restor
defect
secondari
c
cell
influenzainfect
mice
administ
secondari
primari
respons
interestingli
agonist
antibodi
restor
defect
primari
c
tcell
respons
mice
administ
earli
infect
therefor
import
gener
influenzaspecif
c
cell
data
far
suggest
antivir
c
cell
antibodi
affect
manipul
howev
manipul
test
intraperiton
infect
model
data
avail
viru
clearanc
immunopatholog
inhibit
produc
similar
effect
reduc
c
c
antivir
cell
use
fusion
protein
block
interact
ligand
apc
influenzainduc
weight
loss
cachexia
elimin
viru
still
remov
lung
importantli
treatment
benefici
three
day
onset
clinic
symptom
reduct
virusassoci
ill
accompani
reduc
cellular
infiltr
airway
lung
parenchyma
reduct
prolifer
enhanc
apoptosi
lung
cell
account
reduc
cellular
data
partial
support
studi
mice
c
tcell
infiltr
reduc
howev
effect
observ
c
tcell
respons
base
find
tempt
specul
inhibit
ligand
would
produc
similar
effect
import
appreci
reduct
immunopatholog
result
infect
must
balanc
abil
immun
system
clear
viru
prevent
ill
inhibit
although
mhc
tetram
bind
c
cell
reduc
entir
elimin
influenza
viru
inflammatori
therefor
moder
reduct
vigour
inflammatori
respons
might
benefici
without
affect
viru
clearanc
abil
clear
viral
infect
despit
significantli
reduc
lung
inflamm
might
also
reflect
redund
among
late
costimulatori
signal
presenc
intact
innat
antibodymedi
immun
mechan
exampl
inhibit
leav
costimulatori
pathway
intact
hypothesi
consist
effici
control
infect
mice
mice
similarli
recov
influenza
viru
infect
without
display
sign
ill
interrupt
also
express
effector
memori
cell
yet
test
model
lung
viral
infect
understand
synergi
redund
import
examin
antivir
immun
environ
defici
multipl
late
costimulatori
molecul
eg
clear
conclus
vivo
lung
infect
model
reduct
elimin
inflammatori
infiltr
reduc
clinic
manifest
without
compromis
pathogen
clearanc
manner
reduct
achiev
import
manipul
late
costimulatori
molecul
tempt
predomin
express
effector
cell
like
inhibit
would
serv
purpos
although
studi
protect
reinfect
clinic
diseas
requir
follow
manipul
costimulatori
molecul
herpesviru
entri
mediat
hvem
express
memori
cell
express
effector
cell
memori
cell
yet
test
similarli
engag
activ
cell
either
two
ligand
inhibit
tcell
prolifer
cytokin
secret
solubl
form
ligand
agonist
antibodi
might
therefor
limit
excess
tcell
expans
although
yet
test
model
inflammatori
lung
diseas
might
also
possibl
manipul
late
costimulatori
molecul
interf
signal
pathway
tnf
receptor
famili
member
shown
bind
traf
present
appear
inhibit
signal
might
concurr
affect
mani
costimulatori
molecul
manipul
molecul
cell
surfac
redund
exist
could
advantag
although
outcom
inhibit
costimulatori
molecul
clear
mechan
therefor
studi
need
address
whether
manipul
alter
tcell
surviv
cytokin
product
andor
chemokin
receptor
express
pattern
manipul
late
costimulatori
signal
clear
therapeut
potenti
one
hand
reduc
immunebas
disord
asthma
bronchiol
pneumonia
promot
immun
lung
infect
pathogen
problem
treatment
inhibit
late
costimulatori
signal
also
extend
autoimmun
condit
wherea
promot
signal
enhanc
antitumour
immun
might
improv
efficaci
vaccin
natur
compound
use
manipul
costimulatori
signal
requir
signific
thought
product
fusion
protein
antibodi
expens
futur
analysi
exact
bind
region
costimulatori
molecul
review
ligand
might
highlight
specif
epitop
could
use
inhibitor
box
